Trial Profile
Effects of Abatacept on Myocarditis in Rheumatoid Arthritis
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2023
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Adalimumab
- Indications Myocarditis; Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms AMiRA
- 14 Apr 2023 Status changed from recruiting to discontinued.
- 02 Aug 2021 Planned End Date changed from 1 Jul 2021 to 1 Dec 2022.
- 02 Aug 2021 Planned primary completion date changed from 1 Jul 2021 to 1 Nov 2022.